ACC 2026: dulaglutide promotes coronary plaque stabilisation in patients with T2D
Data presented at ACC 2026 suggests that dulaglutide may be stabilising coronary plaques from the inside out, as well as managing diabetes.
Read the full article on the original site.
Read Full Article